|
| Traditional Chinese medicine | Major active ingredients | Models | Animals | Protective effects | Potential mechanisms | Ref. |
|
| Atractylodes macrocephala | Atractylodes macrocephala polysaccharide (AMP) | Hepatic I/RI model | SD rats | Antioxidation stress | NF-κB signaling pathway | Jin et al. [7] |
| Saffron | Saffron ethanol extract (SEE) | Hepatic I/RI model | Wistar rats | Antioxidation stress; inhibition of endoplasmic reticulum stress | — | Pan et al. [8] |
| Breviscapus | Breviscapine | Hepatic I/RI model | SD rats | Antioxidation stress | Mfn2/Ras-PI3K-Akt pathway | Lin et al. [9] |
| Salvia miltiorrhiza | Caffeic acid (CA)/3, 4-dihydroxycinnamic acid | Hepatic I/RI model | SD rats | Antioxidation stress; Anti-inflammatory response | Sirt3 signaling pathway | Mu et al. [10] |
| Caffeic acid (CA)/3, 4-dihydroxycinnamic acid | Liver transplantation model | SD rats, hepatocyte | Antioxidation stress; anti-inflammatory response | PDIA3-NADPH signaling pathway | Mu et al. [11] |
| Magnesium lithospermate B (MLB) | Hepatic I/RI model | C57BL/6 mice | Anti-inflammatory response | NF-κB signaling pathway | Song et al. [12] |
| Tanshinone IIA (Tan IIA) | Hepatic I/RI model | C57BL/6 mice | Anti-inflammatory response | TLR4 signaling pathway | Qi et al. [13] |
| Huperzia serrata | Huperzine A (HupA) | Hepatic I/RI model | Wistar rats | Antioxidation stress; antiapoptosis | — | Xu and Wang [14] |
| Gynostemma pentaphyllum | Gypenoside (GP) | Hepatic I/RI model | C57BL/6 mice | Antioxidation stress; antiapoptosis | — | Zhao et al. [15] |
| Glycyrrhiza uralensis | Glycyrrhizin (GL)/Glycyrrhizic acid | Hepatic I/RI model | SD rats | Antioxidation stress | Nrf2/HO-1 signaling pathway | Kou et al. [16] |
| Tripterygium wilfondii Hook F | Triptolide (diterpenoid triepoxide) | Hepatic I/RI model | C57BL/6 mice, splenocytes | Anti-inflammatory response | STAT3 signaling pathway | Wu et al. [17] |
| Kudzu | Puerarin/7, 4-dihydroxyisoflavone-8β-glucopyranoside | Hepatic I/RI model | SD rats | Anti-inflammatory response | TLR4/NF-κB pathway | Xiao et al. [18] |
| Corydalis yanhusuo | Levo-tetrahydropalmatine (L-THP) | Hepatic I/RI model | BALB/c mice | Anti-inflammatory response; antiapoptosis | ERK/NF-κB pathway | Yu et al. [19] |
| Astragalus membranaceus | Astragaloside IV (AST-IV) | Liver transplantation model | SD rats | Anti-inflammatory response | NF-κB signaling pathway | Chen et al. [20] |
| Chinese medicine mixture | Xuebijing (XBJ) | Hepatic I/RI model | C57BL/6 mice | Anti-inflammatory response | NF-κB signaling pathway | Liu et al. [21] |
| Ginkgo biloba leaf | Ginkgo biloba Dropping Pill (GBDP) | Hepatic I/RI model | C57BL/6 mice, hepatocytes | Antiapoptosis | — | Wang et al. [22] |
| Chinese medicine mixture | Berberine | Liver transplantation model | Wistar rats | Inhibiting endoplasmic reticulum stress | — | Zhang et al. [23] |
|